August 16, 2017 10:54 PM ET

Pharmaceuticals

Company Overview of TARIS BioMedical, Inc.

Key Executives for TARIS BioMedical, Inc.

NameBoard RelationshipsTitleAge
Purnanand Duddu Sarma Ph.D.8 RelationshipsPresident, CEO & Director--
Michael J. Cima Ph.D.38 RelationshipsDirector57
Robert S. Langer Jr., Ph.D., Sc.D.557 RelationshipsDirector68
Diane M. Marcou CPANo RelationshipsChief Financial Officer--
Christopher J. Cutie M.D., MBANo RelationshipsChief Medical Officer--
View More Key Executives

TARIS BioMedical, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Purnanand Duddu Sarma Ph.D. 8 RelationshipsTARIS BioMedical, Inc.--
Michael J. Cima Ph.D. 38 RelationshipsT2 Biosystems, Inc.57
Robert S. Langer Jr., Ph.D., Sc.D. 557 RelationshipsPureTech Health plc68
Edwin M. Kania Jr. 71 RelationshipsFlagship Pioneering59
Dennis Arthur Ausiello M.D. 209 RelationshipsPfizer Inc.71
View All Board Members

TARIS BioMedical, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
424.7K
Bonus
421.0K
Total Short Term Compensation
602.0K
Total Value of Options
8.1M
Compensation as of Fiscal Year
TARIS BioMedical, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

AstraZeneca PLC Announces Retirement of Bruce Burlington as Non-Executive Director and as a Member of the Audit Committee, the Nomination and Governance Committee and as Chairman of the Science Committee, Effective August 31, 2017
August 16, 2017 6:00 AM ET
The Hydroponics Company Limited Announces Executive Changes; Announces its New Registered Office
August 16, 2017 2:33 AM ET
VANC Pharmaceuticals Inc. Appoints Sherif Guorgui to Board of Directors
August 15, 2017 8:29 PM ET
Avenue Therapeutics, Inc. Announces Executive Changes
August 15, 2017 12:00 PM ET
Revive Therapeutics Ltd. Appoints Ram Subramanian as Scientific Advisor for Cannabinoid Based Therapeutics Targeting Liver Diseases
August 15, 2017 11:36 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TARIS BioMedical, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.